内镜下袖状胃成形术治疗肥胖患者的疗效与安全性:荟萃分析
该荟萃分析纳入9项研究共1542例肥胖患者,评估内镜下袖状胃成形术(ESG)的减重疗效与安全性。合并结果显示术后12个月总体重减轻百分比为16.09%、多余体重减轻百分比为59.08%,轻度不良事件合并发生率为72%,严重不良事件仅1%。作者认为ESG是治疗肥胖有前景的微创选择,疗效满意且风险低。
要点
- ESG术后12个月合并%TBWL为16.09%,%EWL为59.08%。
- ESG合并严重不良事件率仅1%,轻度不良事件率为72%。
- ESG或可作为肥胖患者微创减重的替代选择。
核心结论
- ESG是治疗肥胖有前景的微创替代方案,疗效满意且风险低。
- 尽管传统袖状胃切除术仍是减重手术金标准,ESG仍具应用前景。
研究设计与样本
- 检索PubMed、EMBASE、Cochrane和Web of Science截至2019年3月1日的相关文献。
- 共纳入9项研究、1542例患者,提取并合并各随访时点的%TBWL、%EWL及不良事件率。
- 采用随机效应模型绘制森林图进行分析。
主要发现
- 1、3、6、12个月合并%TBWL分别为8.78%(p=0.000)、11.85%(p=0.000)、14.47%(p=0.024)、16.09%(p=0.063)。
- 1、3、6、12个月合并%EWL分别为31.16%(p=0.000)、43.61%(p=0.000)、53.14%(p=0.000)、59.08%(p=0.015)。
- 轻度不良事件合并发生率为72%(p<0.01),严重不良事件合并估计为1%(p=0.08)。
临床怎么用
- 可为肥胖患者咨询ESG作为微创减重选项时提供疗效与安全性的合并数据参考。
- 需结合传统袖状胃切除术作为金标准的地位,个体化选择减重方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic sleeve gastroplasty (ESG) is a minimally invasive, effective, and safe technique for weight loss intervention. Since a relatively small number of cases were present in previous studies, this study aimed to elucidate the efficacy and safety of ESG. METHODS: Relevant publications were identified through searching PubMed, EMBASE, Cochrane, and Web of Science before March 1, 2019. The percentage of total body weight loss (%TBWL), percentage of excess weight loss (%EWL), and the adverse event rate in each follow-up session were extracted, pooled, and analyzed. Forest plots were graphed based on random effects models. RESULTS: A total of 1542 patients from nine studies were eligible for analysis. The pooled results of %TBWL at 1, 3, 6, and 12 months were 8.78% (p = 0.000), 11.85% (p = 0.000), 14.47% (p = 0.024), and 16.09% (p = 0.063), respectively. The pooled results of %EWL at 1, 3, 6, and 12 months were 31.16% (p = 0.000), 43.61% (p = 0.000), 53.14% (p = 0.000), and 59.08% (p = 0.015), respectively. Finally, the pooled rate of mild adverse events was 72% (p < 0.01), and the pooled estimate of severe adverse events was only 1% (p = 0.08). CONCLUSION: Although the conventional surgical sleeve gastrectomy is the gold standard for bariatric surgery, ESG could be a promising minimally invasive alternative for treating obesity with satisfactory efficacy and low risk.
引用
- Li P, Ma B, Gong S, et al. Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis. Surg Endosc. 2019. PMID: 31236722. doi:10.1007/s00464-019-06889-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。